Global Chronic Disease Management Service Market Growth (Status and Outlook) 2023-2029
Chronic disease management services are also referred as enhance primary care. This service is provided to the patient suffering from the chronic or terminal health condition and require multidisciplinary care.
LPI (LP Information)' newest research report, the “Chronic Disease Management Service Industry Forecast” looks at past sales and reviews total world Chronic Disease Management Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Chronic Disease Management Service sales for 2023 through 2029. With Chronic Disease Management Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Disease Management Service industry.
This Insight Report provides a comprehensive analysis of the global Chronic Disease Management Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Disease Management Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Disease Management Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Disease Management Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Disease Management Service.
The global Chronic Disease Management Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Chronic Disease Management Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Chronic Disease Management Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Chronic Disease Management Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Chronic Disease Management Service players cover Cognizant, Phytel, Pegasystems, EXL Healthcare, AxisPoint Health, Philips, HCSC, i2i Systems and HealthSmart Holdings, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Disease Management Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cloud-Based
On-Premise
Segmentation by application
Rehabilitation Centers
Long-term Care Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cognizant
Phytel
Pegasystems
EXL Healthcare
AxisPoint Health
Philips
HCSC
i2i Systems
HealthSmart Holdings
Allscripts
ZeOmega
Harmony Information Systems
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook